N-Geneous Ldl Cholesterol Reagent, N-Geneous Ldl Cholesterol Calibrator, Genzyme Ldl Cholesterol Control Set
Ldl & Vldl Precipitation, Hdl. 510(k) K971573, from Genzyme Corp. (Cambridge, MA). Product code LBR, class 1.
As of Nov 19, 2026, K971573 is an FDA 510(k) held by Genzyme Corp., substantially equivalent on Jun 18, 1997 after 49 days, with no recalls tied to it in FDA's recall database.
- Review time: 49 days
- Recalls: 0
- Cited as a predicate by: 7 devices
Reagents: For the direct, quantitative determination of low-density lipoprotein cholesterol (LDL-C) in human serum or plasma. Calibrators: For the calibration of the N-geneous™ LDL Cholesterol assay in serum or plasma. Controls: To monitor the performance of Genzyme LDL Cholesterol Reagents.
- Ace Ldl-C Reagent, Ldl-C Calibrator, Ldl-C ControlsK991733 · Schiapparelli Biosystems, Inc. · Jul 13, 1999
- Elitech Clincal Systems Cholesterol Hdl SL 2G, Hdl 2G Calibrator, Ldl SL 2G, Ldl 2G Calibrator, Elitrol Ii & Elitech SysK103747 · Elitechgroup Seppim S.A.S. · Aug 31, 2011
- Diazyme Ldl-Cholesterol Reagent, Calibrator and ControlsK072523 · General Atomics · Jan 22, 2008
- Abx Pentra 400: LipoproteinsK060854 · Horiba Abx · Aug 24, 2006
- Ldl-Ex Seiken Assay KitK043264 · Denka Seiken Co., Ltd. · Jan 26, 2005
- Dimension Automated Ldl Cholesterol Flex Reagentcartridge Method, Model DF131K020724 · Dade Behring, Inc. · May 9, 2002
- Synchron Systems Direct Ldl Chloesterol Reagent and CalibratorK014103 · Beckman Coulter, Inc. · Jan 28, 2002
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 30, 1997
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files